Effect of dexmedetomidine versus lorazepam on outcome in patients with sepsis: an a priori-designed analysis of the MENDS randomized controlled trial

Overview of attention for article published in Critical Care, March 2010

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (93rd percentile)
High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

blogs: 2 blogs
policy: 1 policy source

twitter: 5 X users
f1000: 1 research highlight platform

Citations

dimensions_citation: 342 Dimensions

Readers on

mendeley: 321 Mendeley

Summary Blogs Policy documents X Research highlights Dimensions citations

So far, Altmetric has seen 2 posts from 2 blogs.

Dexmedetomidine - Sugar and Spice for the Mechanically Ventilated Patient?

BIJC - ICU Journal Scanner - Article Reviews, 10 Jul 2019

When the FDA approved dexmedetomidine (DEX) in 1999, intensive care medicine had a novel and highly promising drug at its…

REMI 2209. Efecto de la dexmedetomidina sobre la mortalidad y la duración de la ventilación mecánica en pacientes con sepsis

REMI, 22 Apr 2017

ARTÍCULO ORIGINAL: Effect of Dexmedetomidine on Mortality and Ventilator-Free Days in Patients Requiring Mechanical Ventilation…

This page shows the most recent blog posts that mention this research output.

Click here to find out how to access more activity.